Learn how the team builds programs to invest in bold, transformative innovations to develop new drugs and technologies to improve outcomes for patients worldwide.
Amplify was created in 2019 to address the funding gap between basic research or drug discovery and clinical proof-of-concept. Amplify focuses on enhancing the value of pre-commercial projects prior to their commercialization.
Ignite is Brigham and Women’s Hospital’s early-stage innovation acceleration program focused on advancing discoveries with clinical and commercial potential by guiding researchers through the development process.
The Innovation Discovery Grants (IDG) program aims to stimulate new inventive concepts, identify commercially significant scientific strength areas, and accelerate the commercialization of Mass General Brigham intellectual assets.
Mass General Brigham is one of several institutions participating in Lab eN2, a three-way collaboration with Novo Nordisk and Evotec, focused on drug discovery in the cardiometabolic space.
Exploration of novel research for drug discovery and clinical applications.
Pfizer’s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics focuses on accessing cutting-edge science and innovative discoveries aligned with Pfizer’s current core research areas of oncology, inflammation & immunology, rare diseases, and internal medicine.
The Sanofi iAwards Program is designed to accelerate innovative early-stage, disease-relevant research by funding translational research ideas that can contribute to the early-stage innovation pipeline and ultimately address unmet clinical needs.
Collaboration providing early-stage funding and scientific expertise to selected projects across oncology, immunology and neurology.
The Summit Fund was launched with the goal of raising philanthropic support from friends of Mass Eye and Ear to help fast-track the translation of laboratory discoveries into approved medical devices and pharmaceutical treatments to improve the lives of patients.
It is our mission to enable commercialization through the best route for a given technology and ensure that technologies can benefit patients.